Tumor microenvironment responsive metal nanoparticles in cancer immunotherapy
Frontiers in Immunology · 2023
DOI: 10.3389/fimmu.2023.1237361 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Immunology, 2023. Verfasst von Rou Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Science & Sichuan Provincial People'…. Hauptthemen laut MEDLINE: Metal Nanoparticles, Drug-Related Side Effects and Adverse Reactions, Neoplasms. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Malignant tumors have a unique tumor microenvironment (TME), which includes mild acidity, hypoxia, overexpressed reactive oxygen species (ROS), and high glutathione (GSH) levels, among others. Recently, TME regulation approaches have attracted widespread attention in cancer immunotherapy. Nanoparticles as drug delivery systems have ability to modulate the hydrophilicity of drugs to affect drug uptake and efflux in tumor. Especially, the metal nanoparticles have been extensive applied for tumor immunotherapy due to their unique physical properties and elaborate design. However, the potential deficiencies of metal nanoparticles due to their low biodegradability, toxicity and treatment side effects restrict their clinical application. In this review, we briefly introduce the feature characteristics of the TME and the recent advances in tumor microenvironment responsive metal nanoparticles for tumor immunotherapy. In addition, nanoparticles could be combined with other treatments, such as chemotherapy, radiotherapy and photodynamic therapy also is presented. Finally, the challenges and outlook for improving the antitumor immunotherapy efficiency, side effect and potential risks of metal nanoparticles has been discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China,…
Zitieren
APA
Yang, R., Chen, L., Wang, Y., Zhang, L., Zheng, X., Yang, Y., & Zhu, Y. (2023). Tumor microenvironment responsive metal nanoparticles in cancer immunotherapy. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2023.1237361
Vancouver
Yang R, Chen L, Wang Y, Zhang L, Zheng X, Yang Y, et al. Tumor microenvironment responsive metal nanoparticles in cancer immunotherapy. Frontiers in Immunology. 2023. doi:10.3389/fimmu.2023.1237361
BibTeX
@article{Yang2023,
author = {Yang, Rou and Chen, Lu and Wang, Yiling and Zhang, Lijuan and Zheng, Xi and Yang, Yong and Zhu, Yuxuan},
title = {Tumor microenvironment responsive metal nanoparticles in cancer immunotherapy},
journal = {Frontiers in Immunology},
year = {2023},
doi = {10.3389/fimmu.2023.1237361}
}
EUVIMED